Drug Profile
Estradiol valerate/levomefolate
Alternative Names: BAY 987078Latest Information Update: 02 Feb 2015
Price :
$50
*
At a glance
- Originator Bayer HealthCare Pharmaceuticals
- Class Estradiol congeners; Estrenes; Folic acids; Hormonal contraceptives; Hormonal replacements; Oral contraceptives; Vitamins
- Mechanism of Action Estrogen receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Pregnancy
Most Recent Events
- 02 Feb 2015 No development reported - Phase-I for Pregnancy (Prevention) in Germany (PO)
- 01 Mar 2011 Bayer Schering Pharma is now called Bayer HealthCare Pharmaceuticals
- 13 Mar 2010 Bayer completes a phase I trial in Contraception/Pregnancy (Prevention) in Germany